Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0153470 (
Spleen
)
4,015
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The phenotypes observed in mice whose uncoupling protein (Ucp2) gene had been invalidated by homologous recombination (Ucp2(-/-) mice) are consistent with an increase in mitochondrial membrane potential in macrophages and pancreatic beta cells. This could support an uncoupling (proton transport) activity of
UCP2
in the inner mitochondrial membrane in vivo. We used mitochondria from lung or spleen, the two organs expressing the highest level of
UCP2
, to compare the proton leak of the mitochondrial inner membrane of wild-type and Ucp2(-/-) mice. No difference was observed under basal conditions. Previous reports have concluded that retinoic acid and superoxide activate proton transport by
UCP2
.
Spleen
mitochondria showed a higher sensitivity to retinoic acid than liver mitochondria, but this was not caused by
UCP2
. In contrast with a previous report, superoxide failed to increase the proton leak rate in kidney mitochondria, where no
UCP2
expression was detected, and also in spleen mitochondria, which does not support stimulation of
UCP2
uncoupling activity by superoxide. Finally, no increase in the ATP/ADP ratio was observed in spleen or lung of Ucp2(-/-) mice. Therefore, no evidence could be gathered for the uncoupling activity of the
UCP2
present in spleen or lung mitochondria. Although this may be explained by difficulties with isolated mitochondria, it may also indicate that
UCP2
has another physiological significance in spleen and lung.
...
PMID:No evidence for a basal, retinoic, or superoxide-induced uncoupling activity of the uncoupling protein 2 present in spleen or lung mitochondria. 1201 Oct 51